JP2004526706A5 - - Google Patents

Download PDF

Info

Publication number
JP2004526706A5
JP2004526706A5 JP2002564490A JP2002564490A JP2004526706A5 JP 2004526706 A5 JP2004526706 A5 JP 2004526706A5 JP 2002564490 A JP2002564490 A JP 2002564490A JP 2002564490 A JP2002564490 A JP 2002564490A JP 2004526706 A5 JP2004526706 A5 JP 2004526706A5
Authority
JP
Japan
Prior art keywords
oxcarbazepine
solution
methods
heated
toluene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002564490A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526706A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/004065 external-priority patent/WO2002064557A2/en
Publication of JP2004526706A publication Critical patent/JP2004526706A/ja
Publication of JP2004526706A5 publication Critical patent/JP2004526706A5/ja
Pending legal-status Critical Current

Links

JP2002564490A 2001-02-12 2002-02-12 オクスカルバゼピンの新しい結晶形態及びそれらの調製方法 Pending JP2004526706A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26831401P 2001-02-12 2001-02-12
PCT/US2002/004065 WO2002064557A2 (en) 2001-02-12 2002-02-12 New crystal forms of oxcarbazepine and processes for their preparation

Publications (2)

Publication Number Publication Date
JP2004526706A JP2004526706A (ja) 2004-09-02
JP2004526706A5 true JP2004526706A5 (cg-RX-API-DMAC7.html) 2005-12-22

Family

ID=23022405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002564490A Pending JP2004526706A (ja) 2001-02-12 2002-02-12 オクスカルバゼピンの新しい結晶形態及びそれらの調製方法

Country Status (11)

Country Link
US (1) US7183272B2 (cg-RX-API-DMAC7.html)
EP (1) EP1368322A4 (cg-RX-API-DMAC7.html)
JP (1) JP2004526706A (cg-RX-API-DMAC7.html)
AU (1) AU2002250057A1 (cg-RX-API-DMAC7.html)
CA (1) CA2437402A1 (cg-RX-API-DMAC7.html)
DE (1) DE02718948T1 (cg-RX-API-DMAC7.html)
ES (1) ES2211373T1 (cg-RX-API-DMAC7.html)
HU (1) HUP0303154A3 (cg-RX-API-DMAC7.html)
IL (1) IL157351A0 (cg-RX-API-DMAC7.html)
TR (1) TR200400313T3 (cg-RX-API-DMAC7.html)
WO (1) WO2002064557A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2486560A1 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide
GB0223224D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
US20060166968A1 (en) * 2004-07-16 2006-07-27 Sundaram Venkataraman Crystalline form of oxcarbazepine
EP1828098A1 (en) * 2005-11-22 2007-09-05 Teva Pharmaceutical Industries Ltd Crystal forms of cinacalcet hci and processes for their preparation
TWI363058B (en) * 2006-04-05 2012-05-01 Opko Health Inc Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
ES2396051T3 (es) 2006-04-26 2013-02-18 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal
ITMI20062449A1 (it) * 2006-12-19 2008-06-20 Dipharma Spa Forma cristallina di rabeprazolo sodico
ITMI20071502A1 (it) * 2007-07-25 2009-01-26 Archimica Srl Procedimento per la preparazione di formulazioni solide a rilascio controllato contenenti oxcarbazepina e formulazioni ottenibili con tale procedimento
EP2464230B1 (en) * 2009-08-14 2016-10-05 OPKO Health, Inc. Intravenous formulations of rolapitant
WO2011071853A2 (en) 2009-12-07 2011-06-16 Academic Pharmaceuticals Incorporated Parenteral formulation of clopidogrel
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途
AU2019348194B2 (en) 2018-09-28 2025-04-03 Griffith University Agents and methods for modulating pathogen activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) * 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
FI75561C (fi) 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
FR2700117B1 (fr) 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
IT1272897B (it) 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
US6670472B2 (en) 2001-10-09 2003-12-30 Max India Limited Process for the preparation of 10-methoxycarbamazepine
CA2486560A1 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide

Similar Documents

Publication Publication Date Title
CN109311832B (zh) 沃替西汀的帕莫酸盐及其晶型
CN1914212B (zh) Gabaa激动剂的多晶型
WO2005099702A2 (en) R(-)-11-hydroxyaporphine derivatives and uses thereof
US9586904B2 (en) Preparation of (−)-huperzine A
JPH06506442A (ja) 1−(4−アシルアミノフェニル)−7,8−メチレンジオキシ−5h−2,3−ベンゾ−ジアゼピン誘導体及びその酸付加塩、それを含む製薬学的組成物及びその製造方法
WO2018000250A1 (zh) 依鲁替尼新晶型及其制备方法
WO2018076782A1 (zh) 右旋奥拉西坦新晶型及其制备方法和用途
JP2025531344A (ja) 2h-ベンゾトリアゾール誘導体、その調製方法及びそれを含有する医薬組成物
JP2026504208A (ja) ベンゾイソチアゾール化合物、その医薬組成物および用途
EP3624808A1 (en) Methods and compositions for improving sleep
JP2004526706A (ja) オクスカルバゼピンの新しい結晶形態及びそれらの調製方法
CN103694234A (zh) 二氢嘧啶衍生物的晶型
CA1318595C (en) 2-alkoxy-n-(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides
KR20070007888A (ko) 결정질 n-데스메틸클로자핀
CN101062937B (zh) 18α-甘草酸衍生物及其制剂
WO2008080290A1 (en) Selective m4 receptor antagonist and its medical use
JPH06504541A (ja) 4−アミノ−3−アシルキノリン誘導体の塩およびその胃酸分泌抑制剤としての使用
JP2000516257A (ja) タキキニンアンタゴニスト
CN117736193B (zh) 一种氘代稠环化合物及其制备方法与用途
TWI333492B (en) Crystalline topotecan hydrochloride product and preparation thereof
WO2018223819A1 (zh) 一种吲哚乙酸类衍生物及其制备方法和医药用途
WO2023169371A1 (zh) 具有苄氧基芳基醚结构的化合物及其制备方法和用途
JPS5970654A (ja) アントラニル酸誘導体
CN101541717A (zh) 一种反式苯丙烯酸衍生物及其制备方法和应用
CN120737022A (zh) 丁基异吲哚酮类化合物、其制备方法和用途